Project News

A myAirCoach delegation composed by CNet IHP and MyAirCoach coordinator CERTH, will attend CeBIT 2017, the largest Global Event for Digital Business that will be held in Hannover from 20th to 24th March. MyAirCoach was directly selected by the European Commission as one of the top innovator and will be featured at the EU Village at CeBIT.

News and updates regarding the event will be published during the event from the project's twitter account

To what extent physiological, behavioural and environmental data, obtained by mHealth and home-monitoring sensors, as well as patient characteristics, can be used to predict episodes of uncontrolled asthma and the onset of asthma exacerbations?

This is the aim of the observational study recently started at the clinical centres in Leiden, London and Manchester, which will involve 150 asthma patients in daily and weekly measurements.

You can read the protocol of the study here

European Chronic Disease Alliance (ECDA) and the Non Communicable Diseases Alliance (NCDA) recently organized a regional meeting in Brussels to strengthen civil society engagement in the prevention and control of noncommunicable diseases (NCDs) in the WHO European region. European Respiratory Society has also supported the meeting as one of the founding members of ECDA underlining huge burden and difficult issues related to the respiratory conditions.

The IEEE International Conference on Bioinformatics and Biomedicine (Link) will be one of the last events in 2016 for the myAirCoach consortium.
The Centre for Research and Technology Hellas/Information Technologies Institute (CERTH) will present on Saturday 17th December in Shenzhen (China) on “Numerical Assessment of Airflow and Inhaled Particles Attributes in Obstructed Pulmonary System” during the session “Modelling and Data Integration”.

MyAirCoach Infographic summarizing the timeline of test campaigns, the involvement of patients and the utilization of modern technologies for the collection of data towards the better understanding of asthma disease. The results of the test campaigns will also help the project create solutions tailored to the needs of asthma patients, and reveal important aspects of the patients' quality of life.